SPINK1 (TATI; PSTI) (EP401)

SPINK1 (TATI; PSTI) (EP401)

General description


Serine protease inhibitor Kazal-type 1 (SPINK1), also known as tumor-associated trypsin inhibitor (TATI) and pancreatic secretory trypsin inhibitor (PSTI) is a cytosolic trypsin inhibitor secreted by pancreatic acinar cells and foveolar cells of the stomach that protects the gastrointestinal system from premature trypsinogen auto-digestion. Mutations in SPINK1 are associated with hereditary pancreatitis. Recently, SPINK1 demonstrated utility in differentiating hepatocellular carcinoma (HCC) from precancerous lesions. SPINK1 is detected in all hereditary haemochromatosis HCC and most (79%) of HCC cases, but limited to the luminal surface of large bile ducts in normal liver. SPINK1 expression is also detected in neoplasms of the ovary, bladder, kidney, pancreas, colon, lung, and breast. High expression of SPINK1 is often associated with advanced tumor staging, making it a useful prognostic marker.


Other Notes


For a copy of the IFU and CofA contact IVDorder@ABCAM.comFor Technical Service please contact: 800-665-7284 or email: service@cellmarque.com


Physical form


Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and ﹤ 0.1% Sodium Azide


Quality


IVDIVDIVDRUO

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Quality Level Manufacturer Technique(s) Further Info Storage Temp. Form Price Quantity
3573183 SPINK1 (TATI; PSTI) (EP401) 1 ML - SIGMA-ALDRICH immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:100-1:200 For In Vitro Diagnostic Use in Select Regions (See Chart) 2-8°C buffered aqueous solution
Click Add to Quote for price and delivery
-
+
3573184 SPINK1 (TATI; PSTI) (EP401) 0.1 ML 500 SIGMA-ALDRICH - For In Vitro Diagnostic Use in Select Regions (See Chart) 2-8°C buffered aqueous solution
£427.44 (exc VAT) per EACH
-
+